Dr Basho on Treatment Considerations With ADCs in Breast Cancer
Reva K Basho, MD, discusses the use of antibody-drug conjugates across the spectrum of breast cancer subtypes at the 2023 Bridging the Gaps in Breast Cancer meeting.
Ellison Institute Women Cancer Program Providence Specialty Medical Group Revak Basho Cancer Program Breast Cancer
Source: onclive.com